Anders Vahlne
Corporate Officer/Principal bei Karolinska Institutet
Profil
Dr. Anders Vahlne is Chief Executive Officer, Director & Head-Research at Chrontech Pharma AB, a Professor at Karolinska Institutet, and a Member at University College Dublin.
He is on the Board of Directors at Chrontech Pharma AB.
Dr. Vahlne was previously employed as Head-Research by Tripep AB.
Aktive Positionen von Anders Vahlne
| Unternehmen | Position | Beginn |
|---|---|---|
| Karolinska Institutet | Corporate Officer/Principal | 01.11.2010 |
| University College Dublin | Corporate Officer/Principal | 01.11.2010 |
Ehemalige bekannte Positionen von Anders Vahlne
| Unternehmen | Position | Ende |
|---|---|---|
Fastilium Property Group AB
 Fastilium Property Group AB Real Estate DevelopmentFinance Fastilium Property Group AB engages in the development and management of residential and commercial properties. The company was founded on June 7, 2006, and is headquartered in Stockholm, Sweden. | Vorstandsvorsitzender | 17.12.2014 |
Din Bostad Sverige AB
 Din Bostad Sverige AB Real Estate DevelopmentFinance Din Bostad Sverige AB operates a residential property business. The company is headquartered in Huddinge, Sweden. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2006 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Fastilium Property Group AB
Fastilium Property Group AB Real Estate DevelopmentFinance Fastilium Property Group AB engages in the development and management of residential and commercial properties. The company was founded on June 7, 2006, and is headquartered in Stockholm, Sweden. | Finance |
Din Bostad Sverige AB
Din Bostad Sverige AB Real Estate DevelopmentFinance Din Bostad Sverige AB operates a residential property business. The company is headquartered in Huddinge, Sweden. | Finance |
